Position
Fidelity in Agios Pharmaceuticals, Inc.
Back to the book · All holders of AGIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $29.9K$33.83 → $37.11
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 24.3K | $662.4K | — | — | — | 0.0% |
| Q1 2026 | 9.12K | $308.6K | $33.83 | $60.3K | −$414.1K | 0.0% |
| Q2 2026 | 39.1K | $1.45M | $37.11 | $29.9K | $1.11M | 0.0% |